rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2005-4-11
|
pubmed:abstractText |
This study reported the changes in carotid intima-media thickness (IMT) during a 36-month period in 233 HIV-infected patients. Median IMT increased in the first 12 months and then decreased by month 36. The prevalence of treatment with lipid-lowering agents and protease inhibitor-free highly active antiretroviral therapy regimens increased, whereas smoking prevalence decreased. The progression of atherosclerosis in HIV-infected patients can be controlled. The impact of individual measures to reduce the cardiovascular risk should be evaluated further.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
729-31
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15821400-Adult,
pubmed-meshheading:15821400-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15821400-Arteriosclerosis,
pubmed-meshheading:15821400-Carotid Artery, Common,
pubmed-meshheading:15821400-Carotid Artery Diseases,
pubmed-meshheading:15821400-Cholesterol, HDL,
pubmed-meshheading:15821400-Disease Progression,
pubmed-meshheading:15821400-Drug Therapy, Combination,
pubmed-meshheading:15821400-Female,
pubmed-meshheading:15821400-Follow-Up Studies,
pubmed-meshheading:15821400-France,
pubmed-meshheading:15821400-HIV Infections,
pubmed-meshheading:15821400-HIV-1,
pubmed-meshheading:15821400-Humans,
pubmed-meshheading:15821400-Hypolipidemic Agents,
pubmed-meshheading:15821400-Male,
pubmed-meshheading:15821400-Middle Aged,
pubmed-meshheading:15821400-Risk Factors,
pubmed-meshheading:15821400-Smoking,
pubmed-meshheading:15821400-Tunica Intima
|
pubmed:year |
2005
|
pubmed:articleTitle |
Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004.
|
pubmed:affiliation |
INSERM EMI 0338, ISPED, Université Victor Segalen Bordeaux 2, 33076 Bordeaux, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|